Precision BioSciences (DTIL) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Precision BioSciences creates safe methods for treating genetic pathologies thanks to the high precision of the ARCUS system. This chart reflects the current market value on GURU.Markets at 0.00. Precision BioSciences automates genome editing via AI complexes, eliminating routine tasks for researchers. The business relies on a large-scale market for licensing its developments to pharmaceutical behemoths.
Precision BioSciences Inc. - analytical breakdowns and key metrics (DTIL)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- company liabilities and liquidity data:
Debt to Equity Precision BioSciences|DTIL - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Precision BioSciences|DTIL - Aggregate Debt Obligations|Debts to Book Capitalization Precision BioSciences, Inc.|DTIL - Company Long-Term Debt|Company Short-Term Debts Precision BioSciences|Quick Liquidity precisionbiosciences.com
- financial results and valuation multiples details:
DTIL - Company Net Income|Expected Profit Precision BioSciences|DTIL - Business Payback Period|Forward P/E Multiple Precision BioSciences, Inc.|DTIL - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Precision BioSciences, Inc.|DTIL - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Precision BioSciences|DTIL - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months precisionbiosciences.com|DTIL - Earnings per share growth this year|Earnings growth forecast for next year Precision BioSciences
Summary company analysis:Precision BioSciences, Inc. DTIL
To objectively assess asset quality, the ratio of enterprise value to earnings before interest, taxes, depreciation, and amortization is utilized. By analyzing the EV/EBITDA multiple of a company over time, an investor determines the actual payback period of the enterprise, eliminating accounting distortions. For Precision BioSciences (DTIL), this metric reflects the market value of the ARCUS platform relative to its ability to generate cash flow from clinical research.
Who Precision BioSciences competes with
EV/EBITDA Multiple TEM (tempus.com)|Total Company Value to Operating Income Before Depreciation Ratio Qiagen Corp (QGEN)|IONS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio repligen.com RGEN|RNA: EV/EBITDA Multiple|CRSP - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sema4|Company Value to EBITDA Ultragenyx Corp RARE|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Beam Therapeutics Inc. (BEAM)|sarepta.com - Enterprise Value to Operating Income Before Depreciation|Twist Bioscience, Inc. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation TXG|Intellia - EV/EBITDA Multiple|STOK: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BLFS: EV/EBITDA Multiple|WVE - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Maze Therapeutics|Company Value to EBITDA Sionna Therapeutics, Inc. SION|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Prime Medicine Corp (PRME)|Total Company Value to Operating Income Before Depreciation Ratio Taysha Corp|EV/EBITDA Multiple QURE (uniQure N.V.)|MGTX - Enterprise Value to EBITDA Ratio|REGENXBIO - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Solid Biosciences Inc SLDB|OCGN: EV/EBITDA Multiple|Company Value to EBITDA PacBio Corp (PACB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Benitec Biopharma Inc.|Enterprise Value to Operating Income Before Depreciation DSGN (designtx.com)|EV/EBITDA Multiple RCKT|Enterprise Value to EBITDA Ratio 4DMT FDMT|EV/EBITDA Multiple LXEO (Lexeo Therapeutics, Inc.)|Korro Bio Inc. (KRRO) - Company Value to EBITDA|EDIT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio silence-therapeutics.com SLN|PRQR: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation CDXS|Enterprise Value to EBITDA Ratio SGMO|NAUT (Nautilus Biotechnology Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple MGX|Total Company Value to Operating Income Before Depreciation Ratio generationbio.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Boundless Bio BOLD|Exicure Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Celsion Corporation - EV/EBITDA Multiple|PHIO (Phio Pharmaceuticals) - Enterprise Value to Operating Income Before Depreciation|mustangbio.com (MBIO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation RNAZ|BNGO (Bionano Genomics Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple Applied DNA Sciences Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bluebird Bio (BLUE)|IPA: Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Omega Therapeutics OMGA|Business Value to Operating Income Before Depreciation OMIC|Regulus Therapeutics Inc. - EV/EBITDA Multiple|Company Value to EBITDA Syros Pharmaceuticals Inc.|TBIO: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio TRACON Pharmaceuticals, Inc|UBX (Unity Biotechnology) - EV/EBITDA Multiple
